Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Epilepsy Behav ; 4(3): 291-7, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12791331

ABSTRACT

Bilateral symmetrical hippocampal atrophy (BHA) has been implicated as a possible causal element in various neuropsychiatric disorders, in particular depressive disorder and schizophrenia. To test the hypothesis that bilateral symmetrical severe volume loss of the hippocampi is of causal relevance to these psychiatric syndromes rather than an epiphenomenon we assessed the psychopathology in a group of patients with temporal lobe epilepsy (TLE) and very severe bilateral symmetrical hippocampal atrophy and compared it with that of a patient control group. Patients with TLE and hippocampal volumes smaller than three standard deviations below the mean of a control population were identified and compared with a matched patient population with normal hippocampal volumes. Psychopathology was assessed by blinded trained psychiatrists using the Present State Examination and Neurobehavioral Inventory. The prevalence of psychiatric syndromes was high in both patient groups; however, there was no significant difference between the two groups. With use of the more specific Neurobehavioral Inventory a psychopathological pattern reminiscent of the Geschwind syndrome emerged when patients with BHA were characterized by caregivers. While BHA does not result in an increased prevalence of specific psychiatric syndromes, specific symptoms that characterize the Geschwind syndrome like hypergraphia and hyposexuality might be pathogenically related to hippocampal atrophy.


Subject(s)
Epilepsy, Temporal Lobe , Functional Laterality/physiology , Hippocampus/pathology , Adult , Amygdala/pathology , Atrophy/complications , Atrophy/pathology , Atrophy/psychology , Electroencephalography , Epilepsy, Temporal Lobe/complications , Epilepsy, Temporal Lobe/diagnosis , Epilepsy, Temporal Lobe/psychology , Female , Humans , Magnetic Resonance Imaging , Male , Psychomotor Disorders/diagnosis , Psychomotor Disorders/etiology , Severity of Illness Index , Sexual Dysfunctions, Psychological/diagnosis , Sexual Dysfunctions, Psychological/etiology , Syndrome
2.
Br J Med Psychol ; 74(Pt 3): 277-92, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11589322

ABSTRACT

Polyglot psychotic patients can present with either different or less psychotic symptoms depending on the language they use. No known study has used a structured interview to assess such differences. A language history was taken on three patients who were then assessed using the Positive and Negative Syndrome Scale structured interview (SCI-PANSS) for schizophrenia in their two languages. All three patients were found to have different positive symptoms depending on the language used in the interview procedure by the same bilingual researcher. These findings could have important implications in terms of our assessment and treatment of psychotic patients in the NHS. They demonstrate the need to carry out a large study in order to determine how common these findings are in multilingual patients.


Subject(s)
Multilingualism , Psychotic Disorders/psychology , Psychotic Disorders/therapy , Schizophrenia, Paranoid/therapy , Adult , Female , Humans , Language Development , Male , Middle Aged , Risk Assessment , Treatment Outcome
3.
Br J Med Psychol ; 74 Part 3: 277-292, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11802842

ABSTRACT

Polyglot psychotic patients can present with either different or less psychotic symptoms depending on the language they use. No known study has used a structured interview to assess such differences. A language history was taken on three patients who were then assessed using the Positive and Negative Syndrome Scale structured interview (SCI-PANSS) for schizophrenia in their two languages. All three patients were found to have different positive symptoms depending on the language used in the interview procedure by the same bilingual researcher. These findings could have important implications in terms of our assessment and treatment of psychotic patients in the NHS. They demonstrate the need to carry out a large study in order to determine how common these findings are in multilingual patients.

4.
Article in English | MEDLINE | ID: mdl-10082330

ABSTRACT

OBJECTIVE: This article reviews research on the main characteristics of mismatch negativity (MMN) and its applications in neuropsychiatry. BACKGROUND: Event-related potentials (ERPs) have been used to study many aspects of information processing. Mismatch negativity is an early auditory ERP that has been identified as an index of an automatic (preconscious) alerting mechanism stimulating an individual to attend to unexpected environmental events. Disturbances of MMN may relate to abnormalities of auditory information processing contributing to the pathophysiology of neuropsychiatric conditions. METHOD: The authors review (1) studies that have evaluated the electrophysiological aspects of MMN and (2) studies that have investigated the different applications of MMN in neuropsychiatry. RESULTS: The first part of this article describes the characteristics of MMN, its cerebral origins, and electrophysiological parameters. We then discuss the role of "echoic memory" as well as that of attention and vigilance. In the second part of the article, disturbances in MMN associated with schizophrenia, depressive illness, dementing processes, and other neuropsychiatric states are discussed. CONCLUSIONS: MMN is a preconscious cognitive ERP, the main generators and functions of which are well defined. Observations relating to the origins of MMN and its role in early auditory information processing together with its possible behavioral significance, combined with observations of MMN aberrations in psychiatric conditions, may provide novel insights into the pathophysiology of neuropsychiatric states.


Subject(s)
Brain/physiopathology , Psychiatry , Acquired Immunodeficiency Syndrome/physiopathology , Alcoholism/physiopathology , Alzheimer Disease/physiopathology , Arousal/physiology , Attention/physiology , Depressive Disorder/physiopathology , Evoked Potentials , Humans , Mental Disorders/physiopathology , Neurology , Prefrontal Cortex/physiopathology , Schizophrenia/physiopathology
5.
Schizophr Res ; 25(2): 141-8, 1997 May 24.
Article in English | MEDLINE | ID: mdl-9187013

ABSTRACT

Substance misuse among people with schizophrenia is thought to be common and to adversely affect the outcome of the illness. The shortcomings of studies in this area include patient samples that are not epidemiologically-based, and methods for detecting substance misuse that have serious limitations. We investigated the frequency and severity of substance misuse among people with schizophrenia living in the community in London. Interviews were conducted with a community-based sample of 39 people with schizophrenia aged 35 years or less, living in Inner London. The assessments included ratings of psychopathology, movement disorders and substance misuse, and co-informant histories. Urine and hair specimens were analysed for a range of substances. Urine samples were collected from 37 patients and hair samples were provided by 36 patients. Comorbid substance misuse was reported or detected in 63% of the sample. The information elicited using a structured questionnaire for both informants and subjects represented an under-estimate of psychostimulant misuse and opiate misuse compared with the results obtained by hair or urine analysis. Hair analysis revealed that 12 (33%) of those patients providing samples had covertly abused amphetamines, opiates or cocaine in the previous 3 months. The study demonstrated that hair analysis is a well-tolerated, sensitive test for substance misuse. The technique has several advantages over questionnaires and urine analysis for clinical and research purposes. Further applications include the assessment of comorbid substance use in particular groups of patients with schizophrenia, such as during first-episode or psychotic relapse, or those with forensic problems or apparent resistance to treatment.


Subject(s)
Amphetamines/analysis , Central Nervous System Stimulants/analysis , Hair/chemistry , Narcotics/analysis , Schizophrenia/complications , Substance-Related Disorders/complications , Urine/chemistry , Adult , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Radioimmunoassay , Substance-Related Disorders/diagnosis , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...